Bowel Disease Market Research
The urban individuals today are commonly affected by digestive problems among other common health problems. There are many different types of digestive issues, from gastrointestinal infections that make a person miserable but move quickly towards long-term illnesses like inflammatory bowel disease (IBD).
The world market for Inflammatory Bowel Disease (IBD) Therapeutics is projected to go beyond US$4.3 billion by the year 2015. This is primarily driven by prevalence and incidence in the key markets of North America and Europe.
There are two forms of inflammatory bowel diseases, namely Ulcerative colitis and Crohn’s disease, and are considered as a type of autoimmune disorders. Increasing preference for high priced biologics, as against conventional treatment options, is further driving the global market.
The Bowel Disease market research report provides insight into the pipeline status of bowel disease drugs by company and by stage, as well as a summary of the latest news and developments in this area. In addition to new developments and disease specific pipeline projects, the listed reports also contain extensive information in tabular format on a company’s full product pipeline, and products by phase of development with regard to the therapy area. The study also helps in keeping track of the industry-specific competitors and partners by better understanding their product pipeline.
The study basically aims at providing a comprehensive overview of the on-goings of the bowel disease drugs market.